Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ono Pharmaceutical Co. (OPHLF : OTC)

• Company Description    Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. Number of Employees: 4,287

• Price / Volume Information    Yesterday's Closing Price: $14.55 Daily Weekly Monthly 20 Day Moving Average: 1 shares Shares Outstanding: 469.91 (millions) Market Capitalization: $6,837.16 (millions) Beta: 0.33 52 Week High: $18.67 52 Week Low: $9.33 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -4.88% 12 Week -12.87% -19.46% Year To Date 13.06% 3.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8-2 Kyutaromachi 1-chome Chuo-ku - Osaka,M0 541-8564 JPN ph: 816-6263-5670 fax: 816-6263-2950 None http://www.ono-pharma.com

• General Corporate Information    Officers Akira Sagara - Chief Executive Officer; Chairman and Director Takino Toichi - Chief Operating Officer; President and Director Akihiro Tsujinaka - Executive Vice President and Director Masao Nomura - Director Akiko Okuno - Director Peer Information Ono Pharmaceutical Co. (GSAC) Ono Pharmaceutical Co. (CASIF) Ono Pharmaceutical Co. (ALCD.) Ono Pharmaceutical Co. (OMNN) Ono Pharmaceutical Co. (CGPI.) Ono Pharmaceutical Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: J61546115 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/03/26 Share - Related Items Shares Outstanding: 469.91 Most Recent Split Date: 3.00 (5.00:1) Beta: 0.33 Market Capitalization: $6,837.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.93 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/26

• Fundamental Ratios P/E Current FY Estimate: 15.65 Trailing 12 Months: 14.70 PEG Ratio: - Price Ratios Price/Book: 1.24 Price/Cash Flow: 13.50 Price / Sales: 1.98 EPS Growth vs. Year Ago Period: 111.11% vs. Previous Quarter: -97.50% Sales Growth vs. Year Ago Period: 7.09% vs. Previous Quarter: -13.14% ROE 03/31/26 - 8.55 12/31/25 - 7.76 09/30/25 - 6.13 ROA 03/31/26 - 6.58 12/31/25 - 5.91 09/30/25 - 4.64 Current Ratio 03/31/26 - - 12/31/25 - 3.02 09/30/25 - 2.99 Quick Ratio 03/31/26 - - 12/31/25 - 2.56 09/30/25 - 2.50 Operating Margin 03/31/26 - 13.51 12/31/25 - 12.29 09/30/25 - 9.75 Net Margin 03/31/26 - 13.51 12/31/25 - 12.29 09/30/25 - 9.75 Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 11.69 09/30/25 - 11.76 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.10 09/30/25 - 0.11 Debt-to-Capital 03/31/26 - - 12/31/25 - 8.89 09/30/25 - 9.98

Powered by Zacks Investment Research ©